|
CVS Caremark has become the pharmacy for the Rhode Island Free Clinic, dispensing free medicine to more than 2,000 clinic patients at three pharmacy locations – in Cranston, Central Falls and Providence, CVS announced Friday.
more
By Richard Asinof |
|
(Updated, 1:30 p.m.) Rhode Island Hospital was awarded $10.8 million in funding from the National Institutes of Health for research into joint health.
more
By Richard Asinof |
|
Four Rhode Island hospitals – Newport, Kent, South County and Westerly hospitals – will receive an increase totaling $7.1 million increase in Medicare payments for fiscal year 2013.
more
By Richard Asinof |
|
Medical device maker Covidien PLC’s pharmaceutical arm, Mallinckrodt, has completed its acquisition of St. Paul, Minn.-based CNS Therapeutics Inc. for roughly $100 million.
more
By PBN Staff
|
|
The recent layoffs at Landmark Medical Center – 53 since Oct. 30 – are in violation of the collective bargaining agreement, according to Christopher Callaci, general counsel of United Nurses and Allied Professionals.
more
By Richard Asinof |
|
Candescent Partners, the private equity firm that purchased Koch Eye Associates in March, has acquired Dartmouth-based Eye Health Vision Centers.
more
By PBN Staff
|
|
Coastal Medical Inc., Rhode Island’s largest primary care group practice, was one of 89 medical organizations designated as an accountable care organization, the Centers for Medicare and Medicaid Services announced on late Monday.
more
By Richard Asinof |
|
Medical technology maker Covidien PLC reported fourth-quarter earnings of $461 million, or 95 cents per diluted share, a rise of 2.2 percent from the $451 million, or 92 cents per diluted share reported during the same period in 2011.
more
By PBN Staff
|
|
“Healthier employees are happier employees,” said Dina Pescione, a benefits manager at Amica Mutual Insurance Co. And that happiness factor, she says, has a direct correlation with the positive manner in which customer service is delivered, a key focus of what Amica sees as its competitive edge in insurance.
more
By Richard Asinof
Contributing Writer | 8/20/12 |
|
Mallinckrodt, the pharmaceuticals business of biotechnology giant Covidien PLC, has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of its Concerta tablets for the treatment of attention deficit hyperactivity disorder, the company announced Monday.
more
By PBN Staff
|